CommercialCoverageMedium impact
Voice Prosthesis for Voice Rehabilitation Following Total Laryngectomy (CPB 0560, reviewed 2026-08-26)
Aetna·ENT (Ear, Nose & Throat), Oncology, Speech Therapy·Medical Policy
We identified it
Oct 1, 2026
Summary
Aetna has issued a fresh clinical policy (CPB 0560, reviewed 2026-08-26) establishing coverage criteria for voice prosthesis devices used in voice rehabilitation following total laryngectomy. The policy covers indwelling tracheo-esophageal (TE) voice prostheses, hand-held artificial larynx devices, and non-indwelling voice prostheses when recommended by qualified clinicians, with replacement covered every 3-6 months. Pneumatic Bionic Voice Prostheses and TE voice prosthesis insufflators are classified as experimental/investigational and not covered.
Action Required
Immediately: Billing team must review and implement coverage criteria for voice prosthesis claims under Aetna plans. (1) Verify that all claims for CPT 31611, L8500, L8501, L8505, L8507, L8509, L8511-L8515 include documented medical necessity per policy selection criteria and are recommended by a laryngologist or speech-language pathologist—claims lacking this documentation will be denied. (2) Update billing system edits to allow replacement prostheses (L8511-L8515) only within the 3-6 month replacement window; flag claims outside this timeframe for manual review. (3) Configure system to deny all claims for Pneumatic Bionic Voice Prostheses and TE voice prosthesis insufflators as experimental/investigational. (4) Ensure encounter forms and clinical notes capture the treating provider's specialty (laryngologist or SLP) and document the voice rehabilitation indication (total laryngectomy due to malignancy, benign tumor, or carcinoma in situ). (5) Train billing and coding staff on the distinction between covered ICD-10 codes (C32.0-C32.9, D02.0, D14.1, Z85.21) and non-covered codes (Z90.02 acquired absence of larynx without documented qualifying diagnosis).